October JAAD: Adalimumab in conjunction with surgery compared with adalimumab monotherapy for Hidradenitis Suppurativa: A randomized controlled trial in a real-world setting
Oct 10, 2023
Episode Description
Pim Aarts, MD interviewed by Olayemi Sokumbi, MD, FAAD
Proudly Supported by
